1 / 15

Pulmonary Tuberculosis

Pulmonary Tuberculosis. BY: MOHAMED HUSSEIN. Cause. Caused by Mycobacterium tuberculosis (M. tuberculosis ) Gram (+) rod (bacilli). Acid-fast Pulmonary TB occurs in the lungs 85% of all TB cases are pulmonary Extrapulmonary TB occurs in places other than the lungs, including the:

ember
Télécharger la présentation

Pulmonary Tuberculosis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pulmonary Tuberculosis BY: MOHAMED HUSSEIN

  2. Cause • Caused by Mycobacterium tuberculosis (M. tuberculosis) • Gram (+) rod (bacilli). Acid-fast • Pulmonary TB occurs in the lungs • 85% of all TB cases are pulmonary • Extrapulmonary TB occurs in places other than the lungs, including the: • Larynx • Lymph nodes • Brain and spine • Kidneys • Bones and joints • Miliary TB occurs when tubercle bacilli enter the bloodstream and are carried to all parts of the body

  3. Transmission • Spread person to person through airborne particles that contain M. tuberculosis • Transmission occurs when an infectious person coughs, sneezes, laughs, or sings • Prolonged contact needed for transmission • 10% of infected persons will develop TB disease at some point in their lives • 5% within 1-2 years • 5% at some point in their lives • Reactivation due to immune suppression • Infects 1/3rd of the world’s population • Chance of death: 4% • 2nd most common cause of death from an infectious disease in the world. Causing 1.2-145 million deaths a year

  4. Pulmonary Tuberculosis • Primary pulmonary TB (primary exposure) is characterized by the Ghon complex and consists of 1.) subpleural (fissure) focus of inflammation. 2.) Infected (inflamed) lymph nodes draining the primary, subpleural lesion. • A Ghon focus is a primary lesion usually subpleural, often in the mid to lower zones • Secondary pulmonary TB (reactivation) is characterized by a focus of infection and granuloma formation usually in the apex of the lung. The small granulomas (tubercles) eventually coalesce to form larger areas of consolidation with central caseating necrosis. Regional lymph nodes contain caseating granulomas.  • Progressive pulmonary TB: Primary or secondary TB may go on to heal. Caseating granulomas are replaced by fibrosis and calcification. Cases that don’t heal spontaneously or with drug therapy can progress to form cavities or spread to other parts of the lung and to other organs through lymphatic channels and bloodstream. • Milliary tuberculosis.

  5. Necrotizing Granuloma

  6. Miliary Spread

  7. Ghon Complex

  8. Risk Factors • HIV30% develop active disease. • Disease of poverty: Linked to malnutrition and overcrowding. • Drugs: Injection • Prisons, homeless centers • High risk ethnic minorities, healthcare workers • Smoking, diabetes mellitus, alcoholism

  9. Signs/Symptoms • Productive prolonged cough* • Chest pain • Hemoptysis • Fever and chills • Night sweats • Fatigue • Loss of appetite • Weight loss

  10. Diagnosis • Medical history • Physical examination • Mantouxtuberculin skin test • Chest x-ray: Consolidation or cavitation in lung apices. • Sputum Collection: essential to confirm TB • Culture: 2-8 week • Smear, PCR

  11. Treatment • Latent infection: • Daily Isoniazid therapy for 9 months • Monitor patients for signs and symptoms of hepatitis and peripheral neuropathy • Alternate regimen – Rifampin for 4 months • TB Disease: Regimen of 3-4 drugs 1st-line drugs for 6 months. • Isoniazid (INH) • Rifampin (RIF) • Pyrazinamide (PZA) • Ethambutol (EMB) • Recurrent Disease: Test for antibiotic susceptibility and if MDR-TB, treat with at least 4 effective antibiotics for 18-24 months. • Primary vs Secondary resistance • Prevention: BCG vaccine for children

  12. Case A 23-year-old man presented with a 4-week history of coughing, breathlessness and malaise. He had lost 4kg in weight, but had no history of night sweats or haemoptysis. He had returned from holiday in Pakistan 2 months earlier. On examination, he was mildly pyrexial (37.8°C) but had no evidence of anaemia or clubbing. Crepitations were audible over the lung apices; there were no other physical signs. The chest X-ray showed bilateral upper- and middle-lobe shadowing but no hilar enlargement. Sputum was found to contain acid-fast bacilli and Mycobacterium tuberculosis was subsequently cultured. A Mantoux test was strongly positive. A diagnosis of pulmonary tuberculosis was made. The patient was treated with isoniazid and rifampicin for 6 months, together with pyrazinamide for the first 2 months. He was allowed home on chemotherapy when his sputum became negative on direct smear. The chest X-ray is now much improved.

  13. References • 1. http://radiopaedia.org/cases/pulmonary-tuberculosis • 2. http://library.med.utah.edu/WebPath/LUNGHTML/LUNG033.html • 3. http://www.pathpedia.com/education/eatlas/imagepedia/pulmonary_tuberculosis-necrotizing_granuloma.aspx

More Related